Esperion Therapeutics logo
Esperion Therapeutics ESPR
$ 2.49 3.32%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Esperion Therapeutics Total Current Liabilities 2011-2024 | ESPR

Annual Total Current Liabilities Esperion Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
156 M 92.3 M 73.4 M 94.1 M 66.1 M 64.3 M 33.1 M 15.6 M 5.62 M 5.49 M 4.2 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
156 M 4.2 M 55.5 M